As Head of Business Development for the UK and Europe, Alex is responsible for driving the organization’s business development strategies, enhancing the current portfolio, and exploring new business opportunities to maximize growth for RoslinCT.
Alex has over 20 years of experience in the Biologics and ATMP CDMO industry, with a proven track record in Project Management, Account Management and Business Development. Alex trained as a Molecular Biologist before moving into a commercial setting in 2005.
Alex joined RoslinCT UK in July 2022. Her previous roles include Head of Business Development at 3P Biopharmaceuticals, Business Development Director at Charles River Laboratories and Business Development Director at Cobra Biologics.